![Matt Cahill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Matt Cahill is currently the Chief Operating Officer at Qu Biologics, Inc. He previously worked as the Head of Business Operations and Director at Deep Genomics, Inc. Dr. Cahill holds a doctorate from the University of Cambridge and graduate and MBA degrees from the University of Toronto.
Aktive Positionen von Matt Cahill
| Unternehmen | Position | Beginn |
|---|---|---|
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Geschäftsführer | 23.01.2023 |
Ehemalige bekannte Positionen von Matt Cahill
| Unternehmen | Position | Ende |
|---|---|---|
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Geschäftsführer | - |
Ausbildung von Matt Cahill
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Health Technology |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Health Technology |
